Literature DB >> 13106698

Malaria transmission in the Tarai, Naini Tal District, Uttar Pradesh, India.

P C ISSARIS, S N RASTOGI, V RAMAKRISHNA.   

Abstract

A study of the problems of malaria transmission in the Tarai of Naini Tal District, Uttar Pradesh, India, has been made by a WHO Malaria Control Demonstration Team operating in the area between 1949 and 1952.Earlier investigators of malaria transmission in the area had concluded that the fever season coincided with the pre-monsoon period; that Anopheles minimus was the chief vector; and that A. fluviatilis could be dismissed as a zoophilic non-vector.As a result of the team's malariometric and entomological surveys, the following conclusions have been reached: malaria transmission takes place throughout the year; A. minimus is virtually non-existent and plays no part in transmission; A. fluviatilis, the primary vector, is responsible for transmission in the pre- and post-monsoon periods; A. culicifacies, the secondary vector, is responsible for transmission in the monsoon period (July-September).The results of precipitin tests on A. fluviatilis-which gave a gross anthropophilic index of over 40%-indicate that the A. fluviatilis found in this region of India is a mixture of both anthropophilic and zoophilic races; further studies are required to substantiate this theory.

Entities:  

Keywords:  MALARIA/epidemiology; MOSQUITOES

Mesh:

Year:  1953        PMID: 13106698      PMCID: PMC2542115     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  2 in total

1.  Ten years' study (1955-64) of host selection by anopheline mosquitos.

Authors:  L J Bruce-Chwatt; C Garrett-Jones; B Weitz
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

2.  Spleen rates and infant parasite rates as surveillance tool for malaria control in remote hard to reach areas of central India.

Authors:  Manmohan Shukla; Neeru Singh; Mrigendra P Singh
Journal:  Malar J       Date:  2011-12-21       Impact factor: 2.979

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.